Cardiogenic Shock
Open Access
- 10 January 2019
- book chapter
- Published by IntechOpen
Abstract
Cardiogenic shock (CS) is an end-organ hypoperfusion associated with heart failure. Any reason impairing acute left ventricular (LV) or right ventricular (RV) function may cause CS. The only way to avoid CS is to provide early reperfusion in myocardial infarction (MI) patients. CS is characterized by permanent or transient rearrangement of the entire circulatory system. According to the current IABP-SHOCK II trial, 74% of the patients with CSMI are treated with norepinephrine, 53% of them with dobutamine, 26% of them with epinephrine, 4% of them with levosimendan, and 4% of them with dopamine. Percutaneous circulatory support devices such as intra-aortic balloon pump (IABP), LV assist device (LVAD), or extracorporeal life support (ECLS) create treatment options for selected patients such as CS, cardiopulmonary resuscitation, or high-risk pPCI and CABG. Extracorporeal Life Support Organization (ELSO, 2017) evaluated that the use of ECLS/VA-ECMO should be considered when the mortality risk exceeds 50% despite optimal conventional treatment in case of acute severe heart or pulmonary failure, whereas it should be assessed as a primary indication when it exceeds 80%. Early and effective revascularization is the best treatment option for CS. Thus, the organizations on the national and global basis will play the most effective role for the short- and long-term survival of patients.Keywords
This publication has 82 references indexed in Scilit:
- A Tale of Coronary Artery Disease and Myocardial InfarctionNew England Journal of Medicine, 2012
- Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shockCritical Care Medicine, 2010
- Levosimendan vs. Dobutamine: Outcomes for Acute Heart Failure Patients on β-Blockers in SURVIVEEuropean Journal of Heart Failure, 2009
- Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shockInternational Journal of Cardiology, 2007
- A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shockAmerican Heart Journal, 2006
- Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial InfarctionJAMA, 2006
- Restrictive physiology in cardiogenic shock: Observations from echocardiographyAmerican Heart Journal, 2006
- Safety and Efficacy of Left Ventricular Assist Device Support in Postmyocardial Infarction Cardiogenic ShockThe Annals of Thoracic Surgery, 2006
- Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement InitiativeAmerican Heart Journal, 2005
- Cardiogenic Shock After Acute Coronary OcclusionThe Thoracic and Cardiovascular Surgeon, 1989